These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1148591)

  • 1. Relative effectiveness of 12-hourly fractionation and a non-uniform x-ray schedule in the optimum fractionation of C3H mouse mammary tumours.
    Fowler JF; Sheldon PW; Harris SR; Hill SA; Ayres SE
    Br J Radiol; 1975 Jul; 48(571):581-9. PubMed ID: 1148591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosensitization of C3H mouse mammary tumours using fractionated doses of x rays with the drug Ro-07-0582.
    Sheldon PW; Hill SA; Foster JL; Fowler JF
    Br J Radiol; 1976 Jan; 49(577):76-80. PubMed ID: 1276579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimum fractionation in X-ray treatment of C3H mouse mammary tumours.
    Fowler JF; Denekamp J; Sheldon PW; Smith AM; Begg AC; Harris SR; Page AL
    Br J Radiol; 1974 Nov; 47(563):781-9. PubMed ID: 4434003
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose fractionation schedules--biologic aspects and applications to high LET radiotherapy.
    Fowler JF
    J Can Assoc Radiol; 1975 Mar; 26(1):40-3. PubMed ID: 806599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Optimum fractionation in X-ray treatment of C3H mouse mammary tumours.
    Fowler JF; Denekamp J; Sheldon PW; Smith AM; Begg AC; Harris SR; Page AL
    Br J Radiol; 1974 Jun; 47(558):365. PubMed ID: 4835220
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiation administered as a large single dose or in a fractionated schedule: Role of the tumour vasculature as a target for influencing response.
    Horsman MR; Nielsen T; Østergaard L; Overgaard J
    Acta Oncol; 2006; 45(7):876-80. PubMed ID: 16982553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
    Murata R; Tsujitani M; Horsman MR
    Radiother Oncol; 2008 Jun; 87(3):331-8. PubMed ID: 18375007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour regression as a guide to prognosis: a study with experimental animals.
    Denekamp J
    Br J Radiol; 1977 Apr; 50(592):271-9. PubMed ID: 870132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental results with different fractionation regimes and low-LET irradiation of mice (author's transl)].
    Kob D; Kloetzer KH; Arndt J; Kriester A; Magdon E
    Arch Geschwulstforsch; 1976; 46(7):529-37. PubMed ID: 1008669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cure of EMT-6 tumors by X rays or neutrons: effect of mixed-fractionation schemes.
    Rasey JS; Carpenter RE; Nelson NJ; Parker RG
    Radiology; 1977 Apr; 123(1):207-12. PubMed ID: 403569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An historical survey of radiobiology and radiotherapy with fast neutrons.
    Field SB
    Curr Top Radiat Res Q; 1976 Jan; 11(1):1-86. PubMed ID: 1106959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological properties and response to x-rays of first-generation transplants of spontaneous mammary carcinomas in C3H mice.
    Fowler JF; Sheldon PW; Begg AC; Hill SA; Smith AM
    Int J Radiat Biol Relat Stud Phys Chem Med; 1975 May; 27(5):463-80. PubMed ID: 1080142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms underlying reduced growth rate in C3HBA mammary adenocarcinomas recurring after single doses of x-rays or fast neutrons.
    Nelson JS; Carpenter RE; Durboraw D
    Cancer Res; 1976 Feb; 36(2 Pt 1):524-31. PubMed ID: 1260751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutrons.
    Fowler JF; Sheldon PW; Denekamp J; Field SB
    Int J Radiat Oncol Biol Phys; 1976; 1(7-8):579-92. PubMed ID: 977399
    [No Abstract]   [Full Text] [Related]  

  • 15. Fractionation with x rays and neutrons in mice: response of skin and C 3 H mammary tumours.
    Fowler JF; Denekamp J; Page AL; Begg AC; Field SB; Butler K
    Br J Radiol; 1972 Apr; 45(532):237-49. PubMed ID: 4622836
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental study of tumor response to twice-a-day irradiation at smaller doses than 2 Gy].
    Yamakawa M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Jan; 53(1):91-100. PubMed ID: 8441604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
    Horsman MR; Overgaard J
    Radiother Oncol; 2004 Mar; 70(3):301-9. PubMed ID: 15064017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of mouse skin and the C3HBA mammary carcinoma of the C3H mouse to x-rays and cyclotron neutrons: effect of mixed neutron-photon fractionation schemes.
    Nelson JS; Carpenter RE; Parker RG
    Eur J Cancer (1965); 1975 Dec; 11(12):891-901. PubMed ID: 1220974
    [No Abstract]   [Full Text] [Related]  

  • 19. Dependence of response of a C3H mammary carcinoma to fractionated irradiation on fractionation number and intertreatment interval.
    Suit HD; Howes AE; Hunter N
    Radiat Res; 1977 Dec; 72(3):440-54. PubMed ID: 594321
    [No Abstract]   [Full Text] [Related]  

  • 20. Recovery kinetics in mouse skin and CaNT tumours.
    Rojas A; Joiner MC; Johns H
    Radiother Oncol; 1989 Nov; 16(3):211-20. PubMed ID: 2587811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.